Launching an AI-powered medical device in the European Union is a highstakes journey where regulatory strategy and clinical evidence can make or break success.
A robust CEP and CER can accelerate market entry, reduce costs, and prevent regulatory delays. Gain practical insights and first-hand advice from an experienced MedTech founder with a track record in AI-powered devices, and take advantage of the Q&A session to get practical answers and tailored pointers for your own market journey!
Online via MS Teams | Please register HERE!
Registration to the webinar is required in advance. Please note that you will receive the MS Teams link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed. By participating in this webinar, you consent to the sharing of your email address with our SPARK Partners for the sole purpose of providing information and resources related to their certification programs. Your information will not be used for any other purpose without your explicit consent.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
